rxstat › Shortages › Ipilimumab

Ipilimumab (Yervoy) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ipilimumab has no current shortage reported in Canada. It has been in shortage before; the history is below.

An immunotherapy used to treat melanoma and certain other cancers.

Products affected

0 / 1

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Avoided

YERVOY

5MG · SOLUTION LIQUID · BRISTOL-MYERS SQUIBB CANADA

DIN 02379384 · ended Sep 23, 2025 · Delay in shipping of the drug.

Resolved

YERVOY

5MG · LIQUID · BRISTOL-MYERS SQUIBB CANADA

DIN 02379384 · ended Aug 21, 2023 · Disruption of the manufacture of the drug.

Resolved

YERVOY

5MG · LIQUID · BRISTOL-MYERS SQUIBB CANADA

DIN 02379384 · ended Mar 7, 2023 · Disruption of the manufacture of the drug.

What's happening

There are no active shortage reports for Ipilimumab. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Ipilimumab is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XC).

Recent changes

No changes recorded yet.

Common questions

What is Ipilimumab used for?

An immunotherapy used to treat melanoma and certain other cancers.

When will Ipilimumab be back in stock in Canada?

Ipilimumab has no active shortage; supply is normal per Health Canada reports.

Why is Ipilimumab in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (other antineoplastic agents)

Amsacrine (Amsa Pd) Partial shortage 1 of 1 reported products affected Arsenic Trioxide (Trisenox) Partial shortage 1 of 3 reported products affected Bortezomib Partial shortage 2 of 7 reported products affected · est. return Aug 28, 2026 Carboplatin Partial shortage 1 of 3 reported products affected Eribulin Partial shortage 1 of 1 reported products affected · est. return Aug 31, 2027 Erlotinib (Tarceva) Partial shortage 3 of 14 reported products affected · est. return Jun 30, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.